身体活动与糖尿病控制之间的关联:多项横截面研究和基于人口的瑞士队列中的前性研究
Gaël VonLanthen1,2, Pedro Marques-Vidal3,2
1Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
BMJ open
|October 21, 2024
概括
对于2型糖尿病患者 (T2DM) 建议进行体力活动 (PA). 这项研究发现,无论评估方法如何,T2DM患者在控制和不受控制的血糖水平之间没有显著的PA水平差异.
科学领域:
- 内分泌学和新陈代谢学
- 运动生理学 运动生理学
- 公共卫生 公共卫生
背景情况:
- 身体活动 (PA) 对于管理2型糖尿病 (T2DM) 至关重要.
- 在T2DM患者中,血糖控制通常是不理想的.
- 了解与血糖控制相关的PA水平对于有效的管理策略至关重要.
研究的目的:
- 评估和比较2型糖尿病患者的体力活动 (PA) 水平.
- 为了确定T2DM个体之间是否存在PA的差异,控制与不受控制的血糖状况.
- 评估不同PA测量方法 (自我报告与加速度计) 对这些比较的影响.
主要方法:
- 瑞士洛桑的一个潜在队列的截面分析.瑞士洛桑.
- 在三个调查 (2009-2021) 中,通过问卷和加速度计评估了PA.
- 通过血糖或糖化血红蛋白水平定义的T2DM控制.
主要成果:
- 大约一半的T2DM参与者患有失控的血糖.
- 自我报告的PA水平在受控和不受控制的T2DM组之间没有差异.
- 客观评估的PA水平也没有显示控制和不受控制的T2DM组之间的显著差异,无论使用的分析方法.
结论:
- 控制和不受控制的血糖状况的2型糖尿病患者之间没有观察到身体活动水平的显著差异.
- 这些发现突出了在达到T2DM中血糖管理的推PA水平方面的潜在差距.
- 可能需要进一步的研究来确定在这个人群中对PA的障碍和促进因素.
相关概念视频
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
511
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
511
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
237
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
237
Oral Hypoglycemic Agents: Biguanides and Glitazones
176
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
176


